| Michael Best, MD, MPH | |
|
5555 W Thunderbird Rd, Glendale, AZ 85306-4622 | |
| (602) 865-5555 | |
| Not Available |
| Full Name | Michael Best |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 5555 W Thunderbird Rd, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508251174 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 55566 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Estrella Medical Center | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Hospital Based Physicians Arizona Llc | 3274782487 | 398 |
| Vituity - Arizona Hospitalists Pc | 5395163745 | 70 |
News Archive
A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.
Recently, a research team led by Dr. DU Xuemin at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences created a new shape-morphing scaffold, enabling programmed deformation from a 2D planar cell-laden structure to a well-defined 3D tubular shape, which facilitated the facile 3D endothelialization of small-diameter vascular grafts.
Fetal alcohol spectrum disorder is a common condition with a high economic impact in both children and adults, concludes an updated review in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Entity Name | Banner Hospital Based Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275889891 PECOS PAC ID: 3274782487 Enrollment ID: O20121003000752 |
News Archive
A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.
Recently, a research team led by Dr. DU Xuemin at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences created a new shape-morphing scaffold, enabling programmed deformation from a 2D planar cell-laden structure to a well-defined 3D tubular shape, which facilitated the facile 3D endothelialization of small-diameter vascular grafts.
Fetal alcohol spectrum disorder is a common condition with a high economic impact in both children and adults, concludes an updated review in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Entity Name | Leading Healthcare, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356853691 PECOS PAC ID: 1850652496 Enrollment ID: O20180222002817 |
News Archive
A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.
Recently, a research team led by Dr. DU Xuemin at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences created a new shape-morphing scaffold, enabling programmed deformation from a 2D planar cell-laden structure to a well-defined 3D tubular shape, which facilitated the facile 3D endothelialization of small-diameter vascular grafts.
Fetal alcohol spectrum disorder is a common condition with a high economic impact in both children and adults, concludes an updated review in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Entity Name | Vituity - Arizona Hospitalists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770109704 PECOS PAC ID: 5395163745 Enrollment ID: O20200916002069 |
News Archive
A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.
Recently, a research team led by Dr. DU Xuemin at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences created a new shape-morphing scaffold, enabling programmed deformation from a 2D planar cell-laden structure to a well-defined 3D tubular shape, which facilitated the facile 3D endothelialization of small-diameter vascular grafts.
Fetal alcohol spectrum disorder is a common condition with a high economic impact in both children and adults, concludes an updated review in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Best, MD, MPH 5555 W Thunderbird Rd, Glendale, AZ 85306-4622 Ph: (602) 865-5555 | Michael Best, MD, MPH 5555 W Thunderbird Rd, Glendale, AZ 85306-4622 Ph: (602) 865-5555 |
News Archive
A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.
Recently, a research team led by Dr. DU Xuemin at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences created a new shape-morphing scaffold, enabling programmed deformation from a 2D planar cell-laden structure to a well-defined 3D tubular shape, which facilitated the facile 3D endothelialization of small-diameter vascular grafts.
Fetal alcohol spectrum disorder is a common condition with a high economic impact in both children and adults, concludes an updated review in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.
Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.
Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
Ipuole Paulinus Ogar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5555 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
Shiva Shojaie, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5555 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-865-5555 | |
Dr. Veenu Gill, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5620 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-795-7256 Fax: 602-795-7257 | |
Hasan Chaudhry, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20118 N 67th Ave Ste 300-415, Glendale, AZ 85308 Phone: 602-736-8386 | |
Dr. Firoozeh Isfahani, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2631 | |
Dr. Matthew Brownell, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5555 W, Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 |